@No Easy Money During Echo's multiple Gen 1 studies, the MARDS were ~ 12% as compared to the "Gold Standard." Off hand, not sure if patients were compared to DXCM or a clinical chemistry analyzer. Either way, excellent results!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.